Intrinsic Value
CytomX Therapeutics, Inc. (CTMX)
$1.63
-0.05 (-2.98%)
| Enterprise Value | -3,641.84 |
|---|---|
| Net Debt | -3.20 |
| Equity Value | -3,638.64 |
| Shares Outstanding | 73.81 |
| Equity Value Per Share | -49.30 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt